Logo image of NYXH

NYXOAH SA (NYXH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NYXH - BE0974358906 - Common Stock

4.9 USD
+0.09 (+1.87%)
Last: 12/5/2025, 10:47:42 AM
Fundamental Rating

2

Overall NYXH gets a fundamental rating of 2 out of 10. We evaluated NYXH against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of NYXH have multiple concerns. While showing a medium growth rate, NYXH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NYXH has reported negative net income.
In the past year NYXH has reported a negative cash flow from operations.
In the past 5 years NYXH always reported negative net income.
NYXH had a negative operating cash flow in each of the past 5 years.
NYXH Yearly Net Income VS EBIT VS OCF VS FCFNYXH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

NYXH's Return On Assets of -66.28% is on the low side compared to the rest of the industry. NYXH is outperformed by 71.81% of its industry peers.
With a Return On Equity value of -105.18%, NYXH is not doing good in the industry: 63.83% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -66.28%
ROE -105.18%
ROIC N/A
ROA(3y)-31.19%
ROA(5y)-24.1%
ROE(3y)-40.78%
ROE(5y)-30.7%
ROIC(3y)N/A
ROIC(5y)N/A
NYXH Yearly ROA, ROE, ROICNYXH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

NYXH has a better Gross Margin (65.27%) than 68.09% of its industry peers.
In the last couple of years the Gross Margin of NYXH has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for NYXH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5YN/A
NYXH Yearly Profit, Operating, Gross MarginsNYXH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

3

2. Health

2.1 Basic Checks

NYXH does not have a ROIC to compare to the WACC, probably because it is not profitable.
NYXH has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NYXH has been increased compared to 5 years ago.
The debt/assets ratio for NYXH is higher compared to a year ago.
NYXH Yearly Shares OutstandingNYXH Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NYXH Yearly Total Debt VS Total AssetsNYXH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

NYXH has an Altman-Z score of -2.21. This is a bad value and indicates that NYXH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.21, NYXH is not doing good in the industry: 60.64% of the companies in the same industry are doing better.
NYXH has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
NYXH has a Debt to Equity ratio (0.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z -2.21
ROIC/WACCN/A
WACC7.39%
NYXH Yearly LT Debt VS Equity VS FCFNYXH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

NYXH has a Current Ratio of 2.63. This indicates that NYXH is financially healthy and has no problem in meeting its short term obligations.
NYXH's Current ratio of 2.63 is in line compared to the rest of the industry. NYXH outperforms 52.13% of its industry peers.
A Quick Ratio of 2.38 indicates that NYXH has no problem at all paying its short term obligations.
NYXH has a Quick ratio (2.38) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.63
Quick Ratio 2.38
NYXH Yearly Current Assets VS Current LiabilitesNYXH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for NYXH have decreased strongly by -30.42% in the last year.
The Revenue has been growing slightly by 3.98% in the past year.
Measured over the past years, NYXH shows a very strong growth in Revenue. The Revenue has been growing by 74.42% on average per year.
EPS 1Y (TTM)-30.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.02%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y74.42%
Revenue growth 5YN/A
Sales Q2Q%55.77%

3.2 Future

NYXH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.45% yearly.
NYXH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 117.81% yearly.
EPS Next Y-24.84%
EPS Next 2Y-8.36%
EPS Next 3Y3.45%
EPS Next 5YN/A
Revenue Next Year57.01%
Revenue Next 2Y156.82%
Revenue Next 3Y141.05%
Revenue Next 5Y117.81%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NYXH Yearly Revenue VS EstimatesNYXH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
NYXH Yearly EPS VS EstimatesNYXH Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NYXH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NYXH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NYXH Price Earnings VS Forward Price EarningsNYXH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NYXH Per share dataNYXH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.36%
EPS Next 3Y3.45%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NYXH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NYXOAH SA

NASDAQ:NYXH (12/5/2025, 10:47:42 AM)

4.9

+0.09 (+1.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-11 2026-03-11/amc
Inst Owners22.74%
Inst Owner Change-23.67%
Ins Owners22.07%
Ins Owner ChangeN/A
Market Cap210.85M
Revenue(TTM)4.52M
Net Income(TTM)-77.20M
Analysts81.43
Price Target14.63 (198.57%)
Short Float %0.87%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.5%
Min EPS beat(2)-22.16%
Max EPS beat(2)5.16%
EPS beat(4)2
Avg EPS beat(4)-4.61%
Min EPS beat(4)-22.16%
Max EPS beat(4)5.16%
EPS beat(8)6
Avg EPS beat(8)2.91%
EPS beat(12)7
Avg EPS beat(12)-7.28%
EPS beat(16)9
Avg EPS beat(16)-4.34%
Revenue beat(2)0
Avg Revenue beat(2)-19.91%
Min Revenue beat(2)-38.43%
Max Revenue beat(2)-1.4%
Revenue beat(4)0
Avg Revenue beat(4)-21.65%
Min Revenue beat(4)-38.43%
Max Revenue beat(4)-1.4%
Revenue beat(8)1
Avg Revenue beat(8)-22.06%
Revenue beat(12)1
Avg Revenue beat(12)-32.46%
Revenue beat(16)1
Avg Revenue beat(16)-37%
PT rev (1m)-3.57%
PT rev (3m)-3.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.57%
EPS NY rev (1m)-5.7%
EPS NY rev (3m)-5.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 36.64
P/FCF N/A
P/OCF N/A
P/B 2.46
P/tB 8.22
EV/EBITDA N/A
EPS(TTM)-2.62
EYN/A
EPS(NY)-2.47
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)-1.65
OCFYN/A
SpS0.13
BVpS1.99
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.28%
ROE -105.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.27%
FCFM N/A
ROA(3y)-31.19%
ROA(5y)-24.1%
ROE(3y)-40.78%
ROE(5y)-30.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 49.33%
Cap/Sales 29.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.63
Quick Ratio 2.38
Altman-Z -2.21
F-Score3
WACC7.39%
ROIC/WACCN/A
Cap/Depr(3y)64.88%
Cap/Depr(5y)74.74%
Cap/Sales(3y)37.33%
Cap/Sales(5y)219.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.02%
EPS Next Y-24.84%
EPS Next 2Y-8.36%
EPS Next 3Y3.45%
EPS Next 5YN/A
Revenue 1Y (TTM)3.98%
Revenue growth 3Y74.42%
Revenue growth 5YN/A
Sales Q2Q%55.77%
Revenue Next Year57.01%
Revenue Next 2Y156.82%
Revenue Next 3Y141.05%
Revenue Next 5Y117.81%
EBIT growth 1Y-55.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-37.6%
EBIT Next 3Y-16.06%
EBIT Next 5Y11.04%
FCF growth 1Y-45.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.67%
OCF growth 3YN/A
OCF growth 5YN/A

NYXOAH SA / NYXH FAQ

What is the fundamental rating for NYXH stock?

ChartMill assigns a fundamental rating of 2 / 10 to NYXH.


What is the valuation status for NYXH stock?

ChartMill assigns a valuation rating of 0 / 10 to NYXOAH SA (NYXH). This can be considered as Overvalued.


Can you provide the profitability details for NYXOAH SA?

NYXOAH SA (NYXH) has a profitability rating of 1 / 10.